SAB BIOTHERAPEUTICS, INC. (SABSW) Total liabilities 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) total liabilities at each fiscal year-end, per SEC filings.
$21.3MFY2025 · since FY2020: $17.5M → $21.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $21.3M | +17.0% |
| FY2024 | $18.2M | -31.6% |
| FY2023 | $26.6M | +34.2% |
| FY2022 | $19.8M | -53.4% |
| FY2021 | $42.6M | +143.0% |
| FY2020 | $17.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice